SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MRE (medco research) -- Ignore unavailable to you. Want to Upgrade?

To: Harold V who wrote (89)4/28/1998 1:14:00 PM
From: Harold V  Read Replies (1) | Respond to of 192
 
The stock price of MRE is now back up to 20 1/2. The price stayed the same (19 5/8ths) during the sell offs yesterday, and is up 7/8ths at the present time. Among other things, MRE has been recently incorporated into a "New Economy Index" of stocks that includes communication, computer, etc., as well as a few biotech companies like MRE that have shown consistently, over 25%. earnings rises over the last year or so. Even though the stock has risen about 40% since January, this rise to new heights should continue. Harold V



To: Harold V who wrote (89)7/15/1998 9:20:00 PM
From: Sam  Read Replies (1) | Respond to of 192
 
MRE reported $5,220,000 net income and $.48 per share compared to $4,240,000 and $.22 last year. Even better than my optimistic forecast! Sam


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News